Literature DB >> 15501297

Effects of abused inhalants and GABA-positive modulators in dizocilpine discriminating inbred mice.

Keith L Shelton1, Robert L Balster.   

Abstract

There is in vitro evidence that some of the effects of abused volatile solvents may be produced by actions at the NMDA receptor. In addition, some solvents produce phencyclidine-like discriminative stimulus effects. The major goal of the present study was to further compare abused solvents to NMDA antagonists by testing them in two strains of mice trained to discriminate 0.17 mg/kg of the very selective uncompetitive NMDA antagonist, dizocilpine, from saline and contrast those results with several GABA(A)-positive modulators, PCP and ethanol. The results indicated that the discriminative stimulus produced by 0.17 mg/kg dizocilpine was highly specific in both mouse strains. PCP produced 91% dizocilpine-lever responding in C57BL/6J mice, but only 56% dizocilpine-lever responding in DBA/2J mice. Pentobarbital, midazolam and ethanol produced at least some overlap in discriminative stimulus effects with dizocilpine in one or both mouse strains. In contrast, toluene, 1,1,1-trichloroethane (TCE), xylene and methoxyflurane produced saline-appropriate responding almost exclusively. These data indicate that, at least under the specific conditions tested, abused volatile solvents do not have substantial dizocilpine-like discriminative stimulus effects in either C57BL/6J or DBA/2J mice, providing little support that NMDA antagonism plays a central role in the production of this abuse-related effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501297     DOI: 10.1016/j.pbb.2004.07.009

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  N-methyl-D-aspartate receptor channel blocker-like discriminative stimulus effects of nitrous oxide gas.

Authors:  Kellianne J Richardson; Keith L Shelton
Journal:  J Pharmacol Exp Ther       Date:  2014-11-03       Impact factor: 4.030

2.  GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Drug Alcohol Depend       Date:  2011-09-15       Impact factor: 4.492

3.  GABA(A) positive modulator and NMDA antagonist-like discriminative stimulus effects of isoflurane vapor in mice.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Psychopharmacology (Berl)       Date:  2010-08-10       Impact factor: 4.530

4.  Pharmacological characterization of the discriminative stimulus of inhaled 1,1,1-trichloroethane.

Authors:  Keith L Shelton
Journal:  J Pharmacol Exp Ther       Date:  2010-02-01       Impact factor: 4.030

5.  Benzodiazepine-like discriminative stimulus effects of toluene vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Eur J Pharmacol       Date:  2013-11-15       Impact factor: 4.432

6.  Characterization of an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration.

Authors:  Keith L Shelton; Galina Slavova-Hernandez
Journal:  Pharmacol Biochem Behav       Date:  2009-03-04       Impact factor: 3.533

7.  Discriminative stimulus effects of inhaled 1,1,1-trichloroethane in mice: comparison to other hydrocarbon vapors and volatile anesthetics.

Authors:  Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2008-10-30       Impact factor: 4.530

8.  Pharmacological classification of the abuse-related discriminative stimulus effects of trichloroethylene vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  J Drug Alcohol Res       Date:  2014-03-01

9.  Time course of the ethanol-like discriminative stimulus effects of abused inhalants in mice.

Authors:  Scott E Bowen
Journal:  Pharmacol Biochem Behav       Date:  2008-08-08       Impact factor: 3.533

10.  Inhaled toluene vapor as a discriminative stimulus.

Authors:  Keith L Shelton
Journal:  Behav Pharmacol       Date:  2007-05       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.